key: cord-0796019-0971yiy2
authors: Grishin, Andrey M.; Dolgova, Nataliya V.; Landreth, Shelby; Fisette, Olivier; Pickering, Ingrid J.; George, Graham N.; Falzarano, Darryl; Cygler, Miroslaw
title: Disulfide bonds play a critical role in the structure and function of the receptor-binding domain of the SARS-CoV-2 Spike antigen
date: 2021-11-12
journal: J Mol Biol
DOI: 10.1016/j.jmb.2021.167357
sha: 654c032aa47076354e94766be1841110d29f7b1d
doc_id: 796019
cord_uid: 0971yiy2

The current coronavirus pandemic is exerting a tremendously detrimental impact on global health. The Spike proteins of coronaviruses, responsible for cell receptor binding and viral internalization, possess multiple and frequently conserved disulfide bonds raising the question about their role in these proteins. Here, we present a detailed structural and functional investigation of the disulfide bonds of the SARS-CoV-2 Spike receptor-binding domain (RBD). Molecular dynamics simulations of the RBD predict increased flexibility of the surface loops when the four disulfide bonds of the domain are reduced. This flexibility is particularly prominent for the disulfide bond-containing surface loop (residues 456-490) that participates in the formation of the interaction surface with the Spike cell receptor ACE2. In vitro, disulfide bond reducing agents affect the RBD secondary structure, lower its melting temperature from 52°C to 36-39°C and decrease its binding affinity to ACE2 by two orders of magnitude at 37°C. Consistent with these in vitro findings, the reducing agents tris(2-carboxyethyl)phosphine (TCEP) and dithiothreitol (DTT) were able to inhibit viral replication at low millimolar levels in cell-based assays. Our research demonstrates the mechanism by which the disulfide bonds contribute to the molecular structure of the RBD of the Spike protein, allowing the RBD to execute its viral function.

The world has been significantly affected by the current pandemic of SARS-CoV-2 with close to 250 million cases and nearly 5 million deceased as of October 2021.

The family Coronaviridae contains four genera: Alpha-, Beta-, Gamma-and Deltacoronaviruses, in which the Alpha-and Betacoronaviruses include the human pathogens: HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, SARS-CoV, SARS-CoV-2 and MERS-CoV [1] . The first step in infection of human cells, common to all these viruses, involves the binding of the envelope Spike glycoprotein to a cell surface receptor followed by membrane fusion and virus internalization [2, 3] . Different coronaviruses use different surface molecules as receptors: SARS-CoV, SARS-CoV-2 and HCoV-NL63 use angiotensin-converting enzyme 2 (ACE2) [4] [5] [6] ;

MERS-CoV binds to dipeptidyl peptidase-4 (DPP4) with high affinity [7] and to some sialosides with low affinity [8] ; HCoV-229E uses aminopeptidase N (hAPN) [2] ; HCoV-OC43 binds 9-Oacetylated sialic acids [9] ; while HCoV-HKU1 is internalized through an unknown receptor [10] .

The structures of the Spike protein and its domains have been determined for all these human pathogens. The functional Spike protein is a homotrimer, in which each protomer is over 1000 amino acids in length [11] . The Spike protomers consist of two subunits, connected by a linker, which in many coronaviruses is cleaved during maturation. The S1 subunit is responsible for receptor binding [12] and contains the receptor-binding domain (RBD), while the S2 subunit is responsible for membrane fusion [3] . The structures of the Spike proteins and their RBDs from different coronaviruses show that these proteins possess multiple disulfide (S-S) bonds. For example, the Spike protein of SARS-CoV-2 contains 14 disulfide bonds in well-defined regions [13, 14] , while that of MERS-CoV contains 11 [15] and the Spike of HCoV-229E contains 13 S-S bonds [16] . Such an abundance of S-S bridges implies their important structural roles in the formation and stabilization of the proper Spike protein architecture. This is even more prominent for the relatively small RBD, which has four S-S bonds in SARS-CoV-2 [17] [18] [19] , four in MERS-CoV [20, 21] and three in HCoV-229E [22] . Mutations of these cysteine residues (Cys) resulted in either a significant decrease in expression levels or the loss of function.

Specifically, individual mutations of seven Cys residues to alanines (Ala) in the SARS-CoV RBD resulted in two out of seven mutants losing expression and three other mutants losing the ability to bind to ACE2. While only two mutants retained both expression and binding ability, only one of these mutants contained the Cys residue that was involved in the formation of a disulfide bond [23] . The knockout of a single S-S bond in the surface loop of the HCoV-229E RBD that interacts with hAPN resulted in the loss of binding [22] . Similarly, individual mutations of two conserved Cys residues, forming a disulfide bridge in the S2 domain of SARS-CoV, resulted in a drop of membrane fusion capability to 10% of the wild type, with an even greater loss for the double mutant [24] . These data suggest the critical importance of the disulfide bridges for the Spike protein structure and function although our understanding of the precise mechanisms is limited to only general terms.

Respiratory pathways are the main point of entry for SARS-CoV-2 with the epithelial lining fluid (ELF) of the lungs playing a paramount role in protecting airways from a wide range of pathogens, allergens and harmful chemicals. In contrast to most extracellular environments (e.g.

blood serum) possessing oxidizing conditions, ELF has a high reducing potential (-200 mV), similar to the intracellular environment [25] . Experimental evidence of the sensitivity of coronaviruses to reducing conditions is very limited. For the murine leukemia virus, pseudotyped with the Spike protein from SARS-CoV, 3 mM dithiothreitol (DTT) (but not 0.5 mM) could inhibit the entry of the pseudovirus. This result led to the conclusion that SARS-CoV is quite insensitive towards disulfide-reducing agents [26] . A brief in silico molecular modeling study suggested that reduction of only ACE2 disulfide bonds or ACE2 disulfide bonds and SARS-CoV-2 RBD disulfide bonds has a large negative impact on the binding energy, while the reduction of only RBD disulfide bonds does not [27] . A recent experimental publication showed that thiol-reducing agents can inhibit infection with vesicular stomatitis virus infection, pseudotyped with the SARS-CoV-2 Spike protein [28] .

Although it is well known that disulfide bonds stabilize protein architecture, the actual contribution to protein stability and the sensitivity to thiol-reducing agents depends on many factors and is a priori difficult to predict [29] . Here, we provide the mechanistic explanation for the critical role of the disulfide bonds in the structure and function of the SARS-CoV-2 Spike RBD by extensive biophysical investigation of RBD and SARS-CoV-2 viral assays. As predicted by our molecular dynamics simulations, the structure of the RBD becomes more flexible when it is not constrained by four S-S bonds. In particular, the surface loop (residues 456-490) participating in binding to ACE2 undergoes a very fast conformational opening after the S-S bond between Cys480 and Cys488 is reduced. Experimentally, this flexibility is evident by the ability of DTT and tris(2-carboxyethyl)phosphine (TCEP) to affect the secondary structure of the RBD and the ability of DTT, TCEP, N-Acetyl-L-cysteine (NAC) and reduced glutathione (GSH) to decrease the RBD melting temperature (T m ). DTT and TCEP could decrease the T m to as low as 36-39°C. As a consequence of increased flexibility and partial unfolding in the presence of DTT or TCEP at human body temperature, the binding constant of the RBD to ACE2 of 120 nM increases by 100-200 times. Finally, viral propagation in cell-based assays can be inhibited by TCEP and DTT, consistent with the ability to weaken or completely abrogate the Spike RBD -ACE2 interaction.

Disulfide bonds are predicted to rigidify the structure of the RBD domain Many simulations of the Spike protein were conducted to date including an impressive worldwide effort for a 1.2-millisecond simulation of the full-length protein [30] . Nevertheless, the majority of these simulations start from experimental structures possessing intact S-S bonds.

A recent modeling study, exploring the role of the disulfide bonds in the RBD domain, performed by Hati and colleagues, uses relatively short trajectories of only 20 ns [27] . To understand whether disulfide bonds are important in the stabilization of the structure of RBD, we performed six independent molecular dynamics simulations of the RBD domain in water of 2 µs each at 37°C using GROMACS software [31] . The RBD domain (residues 319-541) has four disulfide bonds: C480-C488 is located in the loop interacting with the ACE2 receptor, while the three other S-S bonds, C379-C432, C336-C361 and C391-C525, are located on the opposite side of the RBD domain and do not participate in ACE2 binding. We started with three RBD models, first with all four disulfide bonds intact ("RBD"), second with the single disulfide bond between C480-C488 reduced "RBD (-1 SS)" and third with all S-S bonds reduced "RBD (-4 SS)". Two The most prominent difference is that the ACE2-binding loop remains relatively stable in its "closed" conformation, as seen in the crystal structure, when the disulfide bond C480-C488 is present, but undergoes a structural transition into a series of "open" conformations, not compatible with ACE2 binding, when the disulfide is absent (Figure 2 ). Additional differences are seen for the second trajectory of RBD (-4 SS), where the last 10 C-terminal residues and the first 6 N-terminal residues of the domain adopt a completely random conformation, while the regions around the residues 370 and 390 change their position by up to 7.5 Å. Because of these motions, the second simulation of RBD (-4 SS) has elevated RMSD values ( Figure 1A and 1D).

To increase the sampling of conformational space, we have also conducted one 2 µs simulation for each of the three RBD models at elevated temperature (77°C), which provided additional insight into the ACE2-binding loop conformational equilibrium ( Figure S1 ). Increasing the temperature of simulations is a well-known approach towards efficient conformational sampling used for example in replica exchange molecular dynamics [32, 33] . In these simulations, we see an opening of the ACE2-binding loop in all three trajectories. However, while for RBD (-1 SS) and RBD (-4 SS) the opening happens right at the beginning of the simulations, for RBD with the C480-C488 bond present the loop holds its conformation for at least 1 µs. This result provides additional proof that the disulfide bond plays an important role in stabilizing the loop in ACE2-binding conformation.

Our simulation results agree that without ACE2 the loop may be present in its open conformation, as seen in the cryo-EM structures of the unbound Spike trimer [13, 14] where this loop is disordered. However, the presence of the S-S bond may help in loop stabilization upon binding to the receptor, as seen in the crystal structure of RBD complexed to ACE2 [17] [18] [19] .

Reciprocally, C480-C488 bond reduction causes increased loop fluctuations, as suggested by molecular dynamics, which may render the adoption of the correct bound conformation less favorable energetically.

Disulfide-reducing agents destabilize the Spike RBD structure Since our molecular dynamics results suggest increased flexibility in the RBD domain upon the reduction of disulfide bonds, we investigated whether reagents capable of reducing S-S bonds would introduce structural changes in RBD and ACE2. To this end, we incubated the RBD and ACE2 in the presence of DTT, trans-4,5-dihydroxy-1,2-dithiane (oxidized DTT) or TCEP for 1 hour at 37°C and measured their circular dichroism (CD) spectra at 37°C. Oxidized DTT served as a control compound, being identical to DTT, except for the two thiol groups forming an intramolecular S-S bond. The compounds were added at a final concentration of 2.5 mM, the highest concentration possible without causing a significant increase in the UV light absorption [34] .

Incubation of the RBD at 37°C did not change its CD spectrum as compared to an RBD sample kept at room temperature (RT) ( Figure 3A ), suggesting that the RBD is stable at human body temperature. However, the addition of DTT and TCEP but not oxidized DTT caused a significant change in the CD spectrum of the RBD ( Figure 3A ), indicating changes in the secondary structure composition, induced by disulfide bond reduction. These changes persisted when the samples were cooled and analyzed at RT following the preincubation at 37°C ( Figure S2 ). The same experiments conducted for ACE2 ( Figure 3B ) showed that the addition of DTT or TCEP followed by preincubation and data acquisition at 37°C caused no significant spectral changes, indicating that the ACE2 structure is insensitive to exogenous reducing agents in our experimental conditions. Indeed, ACE2 has only three S-S bonds for a domain of ~600 residues long and none of these bonds are located in the proximity to the RBD binding site.

Having demonstrated these spectral changes in the presence of DTT or TCEP, we next investigated whether reducing compounds affect the melting temperature (T m ) of the RBD.

Indeed, the presence of four S-S bonds in the relatively small RBD domain of 320 residues should provide a significant contribution to its stability. We conducted a melting experiment of the RBD in the presence of 2.5 mM DTT, oxidized DTT and TCEP in which CD spectra were acquired as a function of increasing temperature. The RBD exhibited a T m of 52.1°C (Table 1) To broaden our concentration ranges and to explore more disulfide bond reducers, we used a thermal shift assay in which protein unfolding causes a significant increase in the fluorescence of Sypro® orange dye [35] . We determined the RBD T m values in the presence of DTT, oxidized DTT and TCEP in the concentration range of 0.31 mM -5 mM and monothiols NAC and GSH in the range of 0.62 mM -10 mM (Table 1) . While all compounds, except oxidized DTT, caused an observable decrease in the T m value of RBD, DTT and TCEP were most potent. NAC and GSH had a lesser impact than 0.31 mM DTT or TCEP even when added in 10 mM concentrations. High concentrations of TCEP (2.5 mM and 5 mM) precluded accurate T m determination as at these concentrations melting curves lost their typical sigmoidal shape.

Disulfide-reducing agents decrease the Spike RBD -ACE2 binding affinity Since the presence of reducing agents causes the RBD domain to be less stable, we hypothesized that these compounds should negatively affect the binding affinity of the RBD to its receptor ACE2. We used microscale thermophoresis (MST) to determine the extent to which 2.5 mM DTT, oxidized DTT or TCEP, as well as 10 mM NAC and GSH, would affect the binding. The NAC and GSH also decreased the affinity of the binding between ACE2 and RBD, although the change was not statistically significant even at 10 mM concentration.

To evaluate whether the reduction in binding affinity and partial melting of the RBD would impact viral infectivity, we tested disulfide-reducing agents in cell-based assays. We contrasted DTT and TCEP, which caused a prominent change in the RBD architecture to NAC and GSH, which had a milder effect, and additionally included an approved drug carboxymethyl-cysteine lacking an active SH-ground as a negative control. Viral infectivity assays were conducted by infecting Vero'76 cells with SARS-CoV-2 and determining the virus titer 48 hr later by the tissue culture 50% infectious dose (TCID 50 ) assay. Both cells and the virus were preincubated separately for 1 hr with the compounds. Following thereafter cellular media was discarded and the virus solution containing compounds was added to the cells for 1 hr for infection. Next, the virus was washed away and the cells were incubated for another 48 hr in fresh media in the absence of the compounds, allowing the virus to replicate, after which the viral titers in cell media were determined. In parallel, cell viability was determined using two assays -MTS and resazurin assays, and confirmed by phase-contrast microscopy.

Two independent experiments were performed and the results of the first experiment are presented in Figure 5 , while of the second one - Figure S4 . The two experiments showed largely the same results. Cell viability was unaffected by a 2-hour exposure to the compounds and it was only at the highest concentration of TCEP (20 mM), DTT (20 mM), GSH (160 mM) and NAC (160 mM) where a slight decrease in cell viability was noted. The negative control carboxymethyl-cysteine had no effect on cell viability. Viral propagation, however, was affected by the same compounds that most affected the structure of the RBD in vitro. TCEP and DTT inhibited viral replication in the low mM range, while GSH and NAC had a negligible effect on viral titers if any even at 10-times higher concentrations. The negative control carboxymethyl-cysteine had no effect on viral propagation. To determine to which extent the observed antiviral effect may be related to disulfide bond reduction in other SARS-CoV-2 proteins apart from Spike, we inspected available structures of SARS-CoV-2 proteins in the Protein Data Bank, presently covering a large percentage of the viral proteome. Structures of many protein products of the Orf1ab polyprotein are currently available and all of them have their Cys residues reduced [36] [37] [38] [39] . Apart from Spike, only one additional protein -ORF8 -is rich in disulfide bonds [40] , however, a natural mutation leading to the loss of its expression does not abolish viral infectivity neither in cellular assays nor in the human population [41] . Thus, we considered that Spike is the most likely target of the disulfidereducing agents.

In this paper we show that disulfide bonds play a critical role in maintaining the proper structure of the RBD, allowing for a high-affinity interaction with its cellular receptor ACE2. As expected, DTT and TCEP were much more potent in comparison to NAC and GSH, as the redox potential of monothiols is generally weaker [42] [43] [44] [45] [46] . It is well-known that both the dithiol DTT and the phosphine TCEP are capable of two-electron reduction of disulfide bonds without the involvement of any other species. DTT and TCEP have similar redox potentials (-330 mV and -290 mV, respectively) and form relatively unreactive oxidized products -a six-membered dithiane ring and a phosphine oxide, respectively [47, 48] . The monothiols NAC and GSH, on the other hand, require the presence of two such thiol-containing molecules to reduce disulfide bonds and thus are expected to be inherently less effective.

Many toxins and pathogens rely on the proper redox state of their S-S bonds or sulfhydryl groups for host cell entry. Similar to the SARS-CoV-2 Spike protein, the entry of hepatitis C virus depends on the S-S bond-rich E2 envelope protein and can be blocked by 1 mM DTT [49] .

Additionally, the oxidized status of E2 thiol groups is important for evading the production of neutralizing antibodies [49] . Botulinum neurotoxin B is a complex of 2 chains, connected by a single S-S bond. The reduction of this bond by TCEP prior to the neurotoxin internalization prevents the penetration of the active catalytic chain and saves the cells from intoxication [50] .

The opposite is also true for other toxins and pathogens -disulfide bond reduction and exposure of sulfhydryl groups promotes the internalization of HIV-1 [51] , rotavirus [52] , Newcastle disease virus [53] and diphtheria toxin [54] .

Knowing the sensitivity of the Spike protein towards reducing environments, it would be expected that the ELF of lungs, which possesses reductive properties [25, 55, 56] would antagonize coronaviral entry. The levels of glutathione in ELF are approximately 50-100 times higher than those in blood serum (200-400 M in ELF versus 2-8 M in serum) [55] [56] [57] and approach those in the intracellular environment [58] . Additionally, ELF contains high levels of ascorbic acid and redox-active enzymes, such as superoxide dismutase, catalase, glutathione reductase, glutathione peroxidase, etc. [56] to strengthen its reductive potential.

The first work in this direction used SARS-CoV pseudovirus and demonstrated its relative insensitivity towards DTT [26] , suggesting molecular adaptations of the Spike protein towards tolerating reducing conditions. Our results for SARS-CoV-2 also show that it is in the low mM range that the potent disulfide reducers show their effect. As we improve our knowledge regarding the adaptation of pathogenic strategies towards the redox state of the environment, pathogen sensitivities could be uncovered and potentially used for medicinal purposes. Such work is gaining momentum. Recently, it was shown that N-acetyl cysteine amide (NACA) could inhibit a SARS-CoV-2 pseudovirus infection and the formation of multinucleated cells [28] . A recent manuscript submitted to BioRxiv revealed a promising impact of some approved thiolcontaining drugs on SARS-CoV-2 infectivity and cell entry [59] . The effect of inhibition of viral entry by cysteamine was confirmed in yet another manuscript [60] . One more BioRxiv manuscript explored the idea of an SH-group warhead attached to a delivery polar moiety, which guides the drug molecule to a cryptic pocket in the RBD architecture and positions the SH group in the proximity to a disulfide bond [61] .

Molecular dynamics simulations of the Spike RBD domain were conducted with Gromacs 2019 [31] . For the force field, AMBER99S-ILDN [62] was chosen for the Spike RBD with TIP3P water [63, 64] . The cut-off for Van der Waals and short-range electrostatic interactions was 1.0 nm. Long-range electrostatics were calculated using the Particle Mesh Ewald (PME) approach [65, 66] with a grid spacing of 0.12 nm × 0.12 nm × 0.085 nm. Temperature coupling was done by the v-rescale algorithm [67] to maintain the system temperature of 310°K or 350°K, while the pressure coupling was isotropic and maintained by the Parinello-Rahman algorithm [68, 69] at 1 atm. Rigid bonds between hydrogens and heavy atoms allowed for a 2-fs leap-frog integrator.

The RBD domain was taken from the ACE2 -Spike RBD protein complex structure PDB ID 6LZG [17] . The RBD structure is comprised of residues 333 -527. The sugar moieties were erased from the PDB files. Standard protonation states at pH 7.0 were used, while the only His519 in the RBD structure was protonated at N ε . Three independent simulations were made: 1) RBD with all 4 S-S bonds present as in the X-ray structure (control); 2) RBD with 3 S-S bonds present, while the S-S bond between Cys480 and Cys488 was treated as reduced; and 3) RBD with all 4 S-S bonds reduced. The modeling was conducted in a rhombic dodecahedral box in which the proteins were surrounded by a 10 nm thick layer of water. The system consisted of around 44,000 atoms total, 13,700 water molecules and 2 Clatoms. The systems were minimized by 1000 steps of the steepest descent method. Minimized systems were subjected to further equilibrium simulations, first for 1 ns with all protein atoms restrained, followed by 10 ns with only backbone atoms restrained. The production simulations were conducted for 2 µs, saving the coordinates every 1 ns. Each of the three models was simulated twice for 2 µs per trajectory at 310°K and once at 350°K.

The starting models, topology files, molecular dynamics parameter files and trajectories, compressed to show 10 ns steps, were uploaded to Mendeley Data For spectra acquisition at RT, the proteins were first preincubated with compounds at 2.5 mM final concentration for 1 hr at 37°C, then cooled down to RT. For spectra acquisition at 37°C, the proteins were preincubated with the compounds at 2.5 mM final concentration for 1 hr at 37°C and spectra were acquired at 37°C. RBD with no added compound was also measured at RT without preincubation at 37°C for reference. In parallel, the serially-diluted compounds were added to uninfected control cells, allowed to remain for two hours, after which the compounds were carefully washed away and replaced by fresh media, as described above. Cell viability was determined 48-hours post-exposure. Two cell viability assays were used -CellTiter 96 Aqueous One Solution Assay (Promega; G3580), which yields colored formazan product when metabolically active cells reduce the MTS tetrazolium (Owen's reagent), and resazurin (Alamar Blue, Sigma-Aldrich; R7017) assay, which yields fluorescent resorufin upon reaction with dehydrogenase enzymes of metabolically active cells.

Both assays were conducted according to manufacturers' protocols [70] . Briefly, for the CellTiter Aqueous assay, the cells were incubated with the MTS tetrazolium reagent for 2 hours at 37°C to allow the development of the color and the absorbance values were determined at 490 nm. For resazurin, the growth media was removed and substituted by 100 µl of fresh media, containing 88 µM resazurin. Cells were incubated for 2 hours and the fluorescence was measured at an excitation of 530 nm and emission of 590 nm. The assays were conducted in triplicates in each independent experiment. Statistical Analysis TCID 50 viral titers were plotted against the concentration of compounds. The effective concentration EC 90 was determined as the concentration of compound that reduces the viral titer by 90% when compared to untreated infected control. Both cell viability and viral titer results were plotted and EC 90 values were calculated in GraphPad Prism 9 software, using the nonlinear four-parameter regression analysis, along with a 95% confidence interval (95% CI). mM concentration. Spectra were acquired at 37°C immediately after preincubation. The spectrum of the RBD and ACE2, never exposed to elevated temperatures and acquired at room temperature (RT), is provided for reference. Figure S2 . Comparison of the circular dichroism spectra of RBD. The RBD was preincubated for 1 hour at 37°C in the presence of disulfide-reducing agents at 2.5 mM concentration and cooled down to RT for 30 min. Spectra were acquired at RT. The spectrum of the RBD, never exposed to elevated temperatures and acquired at room temperature (RT), is provided for reference. Figure S3 . The final stage of the purification of A) RBD-tev-his 6 and B) ACE2. The figure shows a gel-filtration curve with Superdex 75 16/600 column followed by the SDS-PAGE image of the consecutive fractions of the peak (marked by an arrow). The RBD has a smeared appearance on the gel due to glycosylation. 

2020 update on human coronaviruses: One health, one world

Human aminopeptidase N is a receptor for human coronavirus 229E

The S2 subunit of the spike glycoprotein of bovine coronavirus mediates membrane fusion in insect cells

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein

Human Coronavirus HKU1 Spike Protein Uses O -Acetylated Sialic Acid as an Attachment Receptor Determinant and Employs Hemagglutinin-Esterase Protein as a Receptor-Destroying Enzyme

Crystal structure of the receptor binding domain of the spike glycoprotein of human betacoronavirus HKU1

Structural proteins of human respiratory coronavirus OC43

Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains

The human coronavirus HCoV-229E S-protein structure and receptor binding

Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Structural basis of receptor recognition by SARS-CoV-2

Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26

Structure of MERS-CoV spike receptorbinding domain complexed with human receptor DPP4

Receptor-binding loops in alphacoronavirus adaptation and evolution

A 193-Amino Acid Fragment of the SARS Coronavirus S Protein Efficiently Binds Angiotensin-converting Enzyme 2

SARS-coronavirus spike S2 domain flanked by cysteine residues C822 and C833 is important for activation of membrane fusion

Glutathione redox control of asthma: From molecular mechanisms to therapeutic opportunities

Significant redox insensitivity of the functions of the SARS-CoV spike glycoprotein: Comparison with HIV envelope

Impact of Thiol-Disulfide Balance on the Binding of Covid-19

Spike Protein with Angiotensin-Converting Enzyme 2 Receptor

Disruption of disulfides within RBD of SARS-CoV-2 spike protein prevents fusion and represents a target for viral entry inhibition by registered drugs

Disulfide bonds and the stability of globular proteins

SARS-CoV-2 simulations go exascale to predict dramatic spike opening and cryptic pockets across the proteome

GROMACS 4.5: A highthroughput and highly parallel open source molecular simulation toolkit

Regulation of Shigella Effector Kinase OspG through Modulation of Its Dynamic Properties

Enhanced sampling techniques in molecular dynamics simulations of biological systems

BeStSel: From Secondary Structure Analysis to Protein Fold Prediction by Circular Dichroism Spectroscopy

Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU from SARS-CoV-2

Mechanism of SARS-CoV-2 polymerase stalling by remdesivir

Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking

Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease

Structure of SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein

Discovery and genomic characterization of a 382-nucleotide deletion in ORF7B and orf8 during the early evolution of SARS-CoV-2

New water-soluble phosphines as reductants of peptide and protein disulfide bonds: Reactivity and membrane permeability

Equilibrium and kinetic constants for the thiol-disulfide interchange reaction between glutathione and dithiothreitol

Direct measurement of the equilibrium between glutathione and dithiothreitol by high performance liquid chromatography

Thiol/disulfide exchange equilibria and disulfidebond stability

Population, acid-base, and redox properties of Nacetylcysteine conformers

Dithiothreitol, a New Protective Reagent for SH Groups

Fluorescence-based detection of thiols in vitro and in vivo using dithiol probes

Contribution of redox status to hepatitis C virus E2 envelope protein function and antigenicity

TCEP treatment reduces proteolytic activity of BoNT/B in human neuronal SHSY-5Y cells

Cell-type specific requirements for thiol/disulfide exchange during HIV-1 entry and infection

Inhibiting Rotavirus Infection by Membrane-Impermeant Thiol/Disulfide Exchange Blockers and Antibodies against Protein Disulfide Isomerase

Role of Thiol/Disulfide Exchange in Newcastle Disease Virus Entry

Cell surface sulfhydryls are required for the cytotoxicity of diphtheria toxin but not of ricin in Chinese hamster ovary cells

Normal alveolar epithelial lining fluid contains high levels of glutathione

Oxidants, antioxidants, and respiratory tract lining fluids

Lung glutathione and oxidative stress: Implications in cigarette smoke-induced airway disease

The glutathione status of cells

One Sentence Summary: Thiol-based drugs decrease binding of SARS-CoV-2 spike protein to its receptor and inhibit SARS-CoV-2 cell entry. Equal Contribution

In Vitro Activity of Cysteamine Against SARS-CoV-2 Variants Alpha, Beta,Gamma and Delta

Thiol-based mucolytics exhibit antiviral activity against SARS-CoV-2 through allosteric disulfide disruption in the spike glycoprotein

Improved side-chain torsion potentials for the Amber ff99SB protein force field

Comparison of simple potential functions for simulating liquid water

A position dependent friction model for solution reactions in the high friction regime: Proton transfer in triosephosphate isomerase (TIM)

Particle mesh Ewald: An N·log(N) method for Ewald sums in large systems

A smooth particle mesh Ewald method

Canonical sampling through velocity rescaling

A molecular dynamics method for simulations in the canonical ensemble

Polymorphic transitions in single crystals: A new molecular dynamics method

Grishin 1* , Nataliya V. Dolgova 1,2 , Shelby Landreth 4 , Olivier Fisette 5

We gratefully acknowledge the use of instruments at the Protein Characterization and 

The authors declare no competing interests. 

The authors declare no competing interests.

Disulfide bonds play a critical role in the structure and function of the receptor-